Bill > HB1473

This bill creates new regulations for drug manufacturers related to contract pharmacies and drug distribution under the federal 340B drug discount program. The bill defines key terms such as "contract pharmacy" (a pharmacy with a contract to dispense drugs on behalf of a covered entity), "covered entity" (an organization participating in a federal drug discount program), and "drug" (a drug purchased at reduced pricing under section 340B of the Public Health Service Act). It establishes several prohibited actions for manufacturers, their agents, affiliates, and third-party logistics providers, which include: denying a contract pharmacy's ability to acquire drugs for a covered entity, prohibiting drug dispensing, requiring unnecessary data submissions, interfering with drug dispensing to eligible patients, and offering rebates instead of point-of-sale discounts. Violations of these provisions would be classified as a class B misdemeanor, with an exception for limited drug distributions as required by federal law. The bill aims to protect the rights of contract pharmacies and covered entities in obtaining and dispensing discounted drugs, ensuring they can effectively serve their patients without undue interference from drug manufacturers.

Business and Industry, Government Affairs

https://ndlegis.gov/assembly/69-2025/regular/bill-overview/bo1473.html